Organogenesis shareholders elect 9 directors, approve say-on-pay and auditor at annual meeting

At the Annual Meeting, our stockholders also approved, on an advisory basis, the compensation paid to our named executive officers. The votes cast on this proposal were as follows: Proposal Votes For Votes Against Abstentions Broker Non-Votes To approve, on an advisory basis, the compensation paid to our named executive officers. 72,516,011 12,722,258 61,328 44,264,824

At the Annual Meeting, each of Robert Ades, Michael J. Driscoll, Prathyusha Duraibabu, Jon Giacomin, Gary S. Gillheeney, Sr., Michele Korfin, Arthur S. Leibowitz, Glenn H. Nussdorf and Gilberto Quintero was elected our Director, to serve until the next Annual Meeting of Stockholders and until their successors are elected and qualified. The votes cast in the election of the directors were as follows: Nominee Votes For Votes Withheld Broker Non-Votes Robert Ades 85,064,304 235,293 44,264,824 Michael J. Driscoll 76,582,548 8,717,049 44,264,824 Prathyusha Duraibabu 76,767,319 8,532,278 44,264,824 Jon Giacomin 64,825,495 20,474,102 44,264,824 Gary S. Gillheeney, Sr. 76,736,718 8,562,879 44,264,824 Michele Korfin 76,707,741 8,591,856 44,264,824 Arthur S. Leibowitz 76,682,590 8,617,007 44,264,824 Glenn H. Nussdorf 61,049,018 24,250,579 44,264,824 Gilberto Quintero 76,572,688 8,726,909 44,264,824

At the Annual Meeting, our stockholders also approved the proposal to ratify the appointment of RSM US LLP as our independent registered public accounting firm for our fiscal year ending on December 31, 2026. The votes cast on this proposal were as follows: Proposal Votes For Votes Against Abstentions Broker Non-Votes To ratify the appointment of RSM US LLP as our independent registered public accounting firm for fiscal year 2026. 128,421,160 856,933 286,328 0